Clinical trial

Radium-223 in Combination With Enzalutamide

NCT02225704

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-06-03

PhasePHASE2

Study timeline

Study start (actual)2015-06-03Date precision: day

Registry last updated2026-04-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Radium-223 and enzalutamideDRUG

Sponsors & collaborators

Cancer Trials Irelandlead sponsor

Mapped research locations

DublinIreland5

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02225704 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.